Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
40
Purchases
0
Sales
40
Purchase value
$0.00
Sale value
$22.24M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 13, 2026Period of report Jul 9, 20260001759655-26-000057
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 9, 2026
Common Stock, par value $0.01 per shareF1F2
21,275
$27.67
$588.68K
164,853
Direct
Filing footnotes · 2
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Filed Jul 9, 2026Period of report Jul 7, 20260001858396-26-000016
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 7, 2026
Common Stock, par value $0.01 per shareF1F2
600
$27.57
$16.54K
186,128
Direct
Filing footnotes · 2
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.55 to $27.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Filed Jul 7, 2026Period of report Jul 2, 20260001401958-26-000010
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 6, 2026
Common Stock, par value $0.01 per shareF1F3F4
53,722
$27.24
$1.46M
68,188
Direct
SaleJul 2, 2026
Common Stock, par value $0.01 per shareF1F2
59,037
$27.33
$1.61M
76,651
Direct
Filing footnotes · 5
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.09 to $27.39 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4Reflects the forfeiture of 8,463 unvested restricted stock units granted on May 20, 2026 under the Issuer's 2021 Omnibus Incentive Plan.
F5All of the stock options are fully vested and exercisable.
Filed Jul 7, 2026Period of report Jul 2, 20260001858396-26-000014
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 2, 2026
Common Stock, par value $0.01 per shareF1F2
24,734
$27.50
$680.19K
186,728
Direct
Filing footnotes · 2
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.51 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Filed Jul 2, 2026Period of report Jun 30, 20260001759655-26-000053
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 1, 2026
Common Stock, par value $0.01 per shareF1F3
45,634
$26.52
$1.21M
113,692
Direct
SaleJul 1, 2026
Common Stock, par value $0.01 per shareF1F4
37,041
$26.93
$997.51K
76,651
Direct
SaleJun 30, 2026
Common Stock, par value $0.01 per shareF1F2
52,823
$25.72
$1.36M
76,651
Direct
Filing footnotes · 5
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5All of the stock options are fully vested and exercisable.
Filed Jun 30, 2026Period of report Jun 26, 20260001759655-26-000048
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 29, 2026
Common Stock, par value $0.01 per shareF1F3
63,212
$25.33
$1.60M
76,651
Direct
SaleJun 26, 2026
Common Stock, par value $0.01 per shareF1F2
88,110
$25.33
$2.23M
76,651
Direct
Filing footnotes · 4
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.70 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.14 to $25.67 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4All of the stock options are fully vested and exercisable.
Filed Jun 30, 2026Period of report Jun 26, 20260001759655-26-000046
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 26, 2026
Common Stock, par value $0.01 per shareF1F2
17,196
$25.18
$433.00K
211,462
Direct
Filing footnotes · 3
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3All of the stock options are fully vested and exercisable.
Filed May 13, 2026Period of report May 11, 20260001759655-26-000030
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 12, 2026
Common Stock, $0.01 par value per shareF3
15,647
$22.64
$354.25K
434,357
Direct
SaleMay 11, 2026
Common Stock, $0.01 par value per shareF1F2
105,439
$22.55
$2.38M
450,004
Direct
Filing footnotes · 3
F1Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Filed May 13, 2026Period of report May 11, 20260001858396-26-000011
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 11, 2026
Common Stock, par value $0.01 per shareF1
3,385
$22.60
$76.50K
211,462
Direct
Filing footnotes · 1
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Filed May 5, 2026Period of report May 1, 20260001858396-26-000009
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 4, 2026
Common Stock, par value $0.01 per shareF1
1,206
$25.00
$30.15K
214,847
Direct
SaleMay 1, 2026
Common Stock, par value $0.01 per shareF1F2
7,179
$25.03
$179.69K
214,847
Direct
Filing footnotes · 3
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3All of the stock options are fully vested and exercisable.
Filed May 5, 2026Period of report May 1, 20260001759655-26-000020
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 4, 2026
Common Stock, par value $0.01 per shareF1F3
1,017
$24.96
$25.38K
68,188
Direct
SaleMay 1, 2026
Common Stock, par value $0.01 per shareF1F2
17,096
$24.99
$427.23K
68,188
Direct
Filing footnotes · 4
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $24.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4All stock options are fully vested and exercisable.
Filed Apr 6, 2026Period of report Apr 2, 20260001858396-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 2, 2026
Common Stock, par value $0.01 per shareF1
5,566
$20.85
$116.05K
214,847
Direct
Filing footnotes · 1
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Filed Mar 18, 2026Period of report Mar 16, 20260001858398-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 16, 2026
Common Stock, $0.01 par value per shareF1
26,509
$22.11
$586.11K
555,443
Direct
Filing footnotes · 1
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Filed Mar 18, 2026Period of report Mar 16, 20260001759655-26-000019
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 16, 2026
Common Stock, par value $0.01 per shareF1
6,391
$22.11
$141.31K
220,413
Direct
Filing footnotes · 1
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Filed Mar 16, 2026Period of report Mar 12, 20260001858398-26-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 13, 2026
Common Stock, $0.01 par value per shareF1
27,229
$21.52
$585.97K
581,952
Direct
SaleMar 12, 2026
Common Stock, $0.01 par value per shareF1
26,763
$21.90
$586.11K
609,181
Direct
Filing footnotes · 1
F1The sales reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Filed Mar 16, 2026Period of report Mar 12, 20260001858396-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 13, 2026
Common Stock, par value $0.01 per shareF1
6,565
$21.52
$141.28K
226,804
Direct
SaleMar 12, 2026
Common Stock, par value $0.01 per shareF1
6,453
$21.90
$141.32K
233,369
Direct
Filing footnotes · 1
F1The sales reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Filed Mar 12, 2026Period of report Mar 10, 20260001858398-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 10, 2026
Common Stock, $0.01 par value per shareF1F2
21,097
$22.71
$479.11K
322,698
Direct
Filing footnotes · 4
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person .
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.27 to $23.23 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
F4Vesting and distribution to reporting person of 141,948 shares underlying performance stock units that were granted on May 9, 2023, and 29,956 shares underlying performance stock units that were granted on July 1, 2023, in both cases for the performance period 2023-2025.
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000018
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF2F3
21,915
$22.84
$500.54K
363,879
Direct
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF2F4
1,219
$23.37
$28.49K
362,660
Direct
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF1
18,865
$22.84
$430.88K
343,795
Direct
SaleMar 6, 2026
Common Stock, $0.01 par value per shareF1
21,440
$23.15
$496.34K
385,794
Direct
Filing footnotes · 4
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.35 to $23.34 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.35 to $23.41 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000016
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF1
4,949
$22.84
$113.04K
83,711
Direct
SaleMar 6, 2026
Common Stock, $0.01 par value per shareF1
4,394
$23.15
$101.72K
88,660
Direct
Filing footnotes · 1
F1The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000015
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 9, 2026
Common Stock, par value $0.01 per shareF1
5,829
$22.84
$133.13K
161,903
Direct
SaleMar 6, 2026
Common Stock, par value $0.01 per shareF1
5,177
$23.15
$119.85K
167,732
Direct
Filing footnotes · 1
F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Filed Mar 2, 2026Period of report Feb 26, 20260001759655-26-000013
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 27, 2026
Common Stock, par value $0.01 per shareF1F3
7,697
$25.05
$192.81K
172,909
Direct
SaleFeb 26, 2026
Common Stock, par value $0.01 per shareF1F2
5,361
$25.00
$134.03K
172,909
Direct
Filing footnotes · 4
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4All of the stock options are fully vested and exercisable.
Filed Mar 2, 2026Period of report Feb 26, 20260001401958-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 27, 2026
Common Stock, par value $0.01 per shareF1F3
16,550
$25.00
$413.75K
68,188
Direct
SaleFeb 26, 2026
Common Stock, par value $0.01 per shareF1F2
7,788
$24.99
$194.62K
68,188
Direct
Filing footnotes · 4
F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.13 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4All of the stock options are fully vested and exercisable.
Filed Dec 16, 2025Period of report Dec 12, 20250001759655-25-000116
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 12, 2025
Common Stock, par value $0.01 per shareF1F2
23,887
$25.03
$597.89K
172,909
Direct
Filing footnotes · 3
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3All of the stock options are fully vested and exercisable.
Filed Dec 16, 2025Period of report Dec 12, 20250001401958-25-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 12, 2025
Common Stock, par value $0.01 per shareF1F2
13,647
$25.01
$341.31K
68,188
Direct
Filing footnotes · 3
F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.105 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3All of the stock options are fully vested and exercisable.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.